--:--:--
Stockwatch Reports
…

News Reports / Consumer Defensive / INGR

INGRIngredion Incorporated

NYSE · Consumer Defensive · Mkt cap $5.7B · Avg vol 678.14K

$91.11

-6.31 (-6.48%)

Quote as of November 6, 2026, 1:14 PM ET

News Impact Report · Published November 6, 2026, 11:18 AM ET

INGR: Ingredion Posts $393M Net Income in Q2 FY2026 as Stock Falls 5.4%

Share

Filed with the SEC on November 5, 2026 | Form 8-K (Items 2.02, 9.01) Current Price: $92.18 | Today's Change: -5.38%


What Happened

Ingredion Incorporated filed an 8-K with the SEC on November 5, 2026, disclosing its Q2 FY2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The company reported net income of $393 million and operating income of $547 million on revenue of $3.646 billion for the quarter. Diluted earnings per share came in at $5.99, with basic EPS of $6.09, representing a material earnings disclosure that investors are now absorbing.


Why It Matters

Despite what appear to be substantial headline profit figures, the market's reaction has been sharply negative — shares are down 5.38% on the day of this report. This divergence between reported profitability and stock performance suggests the results may have fallen short of investor expectations or forward guidance may have disappointed, though any specific guidance figures are not provided in the XBRL data extracted from this filing. Key takeaways for investors:

  • Revenue of $3.646 billion and operating income of $547 million represent a healthy operating margin of approximately 15% — a figure that speaks to Ingredion's core ingredient-solutions business.
  • Net income of $393 million and diluted EPS of $5.99 are notable in absolute terms, but market reaction indicates these may have been anticipated or already priced in.
  • The gap between basic EPS ($6.09) and diluted EPS ($5.99) is modest, suggesting limited dilution from stock-based compensation or convertible instruments.
  • Investors should note that this filing was made after market close, meaning the full market reaction is still being processed.

Analysis

The headline numbers from Ingredion's Q2 FY2026 disclosure are operationally solid — a 15% operating margin on $3.6 billion in revenue is not a business in distress. Yet the stock's swift 5.4% decline signals that the market was likely positioned for more, whether in terms of revenue growth, margin expansion, or forward outlook. Without guidance figures in the structured XBRL data from this filing, it is not possible to pinpoint exactly what disappointed — but the magnitude of the selloff warrants attention.

The disconnect between strong reported profitability and a falling share price is a classic earnings-day pattern when results meet but do not beat expectations. Investors will want to watch for:

  • Management commentary and guidance provided in the accompanying earnings call or press release, which may clarify the market's reaction.
  • Year-over-year comparisons, which are not available in this filing's XBRL data but would provide important context on whether these results represent improvement or deterioration.
  • Segment-level performance, particularly given Ingredion's diversified exposure across food, beverage, and industrial starch markets globally.

This filing coincides with the initiation of StockWatch's coverage of INGR — readers may wish to consult that report for a deeper fundamental framework on the company.


Disclaimer

This report is a news and informational summary of a publicly filed SEC disclosure. It does not constitute investment advice, an offer to buy or sell securities, or a research recommendation of any kind. All financial figures cited are sourced exclusively from the XBRL data attached to the referenced SEC filing. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions.

Existing Coverage

StockWatch has full coverage on INGR, published 2026-11-06. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-05. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1046257/000162828026070486/ingr-20261105.htm

StockWatch initiated coverage · November 6, 2026

INGR: Ingredient Science, Sugar Reduction and a Defensive Cash Machine

Valuation has compressed to the low end of the range. At $93.16 the shares sit just $1.15 above the 52-week low of $92.01 and roughly 25% below the 52-week high of $123.49, putting the stock on approximately 10.6x trailing EPS of $8.81 and a $5.8B market capitalization. That is a discount valuation for a business with a 0.62 beta and a specialty-ingredient mix that has been rising as a share of gross profit.

-2.2%

Read the full report →

-2.2%

Key Data

Last

$92.18

P&L ($)

$-5.24

P&L (%)

-5.38%

Day Range

$90.19 - $94.22

Volume

201.00K

Market Cap

$5.7B

Previous Close

$97.42

Open

$93.05

52 Week Range

$90.19 - $123.49

Shares Outstanding

63.06M

Public Float

61.92M

Average Volume

678.14K

As of November 6, 2026, 12:52 PM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc